In the reserpine quinpirole induced rat model of PD, reduced akinesia was further reduced upon treatment with WIN 55,212-2 as a specific agonist of CBRs, whereas this effect of WIN 55,212-2 was blocked in the presence of CB1 antagonist rimonabant (SR141716A) [437]. Here, CNR1 is linked to Parkinson disease.